Stocks · Health care · Pharmaceutical Preparations

Bausch Health Companies Inc.

BHC Clue Score44
Quebec, Canada Fiscal year ends December CIK 0000885590 Results filed 28 Oct 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Paulson & Co. Inc.
25 Nov 2025
10% owner
Buy indirect
2,500,000
$6.25
$15.63M
John Paulson
14 Aug 2025
Director
Buy indirect
34,721,118
$9.00
$312.49M
John Paulson
13 Aug 2025
Director
Buy indirect
86,409
$7.06
$610.05K
John Paulson
12 Aug 2025
Director
Buy indirect
1,156,640
$6.88
$7.96M
John Paulson
11 Aug 2025
Director
Buy indirect
2,000,000
$6.35
$12.70M
John Paulson
13 Jun 2025
Director
Buy indirect
3,564,059
$5.94
$21.17M
John Paulson
12 Jun 2025
Director
Buy indirect
1,005,376
$5.47
$5.50M
John Paulson
11 Jun 2025
Director
Buy indirect
1,029,098
$5.24
$5.39M
John Paulson
10 Jun 2025
Director
Buy indirect
754,134
$5.05
$3.81M
Steven D Miller
30 Nov 2021
Director
Buy indirect
10,000
$24.17
$241.70K
Steven D Miller
30 Nov 2021
Director
Buy
50,000
$24.24
$1.21M
Eschenbach Andrew C. Von
5 Aug 2021
Director
Buy
1,400
$25.94
$36.32K
Schutter Richard U De
4 Aug 2021
Director
Buy
10,000
$25.01
$250.12K
ValueAct Holdings, L.P.
5 Jun 2020
Director
Buy indirect
948,353
$19.24
$18.25M
John Paulson
14 May 2020
Director
Buy indirect
585,100
$15.92
$9.31M
John Paulson
14 May 2020
Director
Buy indirect
624,900
$15.87
$9.92M
John Paulson
14 May 2020
Director
Buy indirect
70,000
$15.65
$1.10M
John Paulson
14 May 2020
Director
Buy indirect
348,920
$15.85
$5.53M
John Paulson
13 May 2020
Director
Buy indirect
645,844
$16.70
$10.79M
John Paulson
13 May 2020
Director
Buy indirect
80,300
$16.58
$1.33M
John Paulson
13 May 2020
Director
Buy indirect
603,900
$16.32
$9.86M
John Paulson
12 May 2020
Director
Buy indirect
799,900
$17.24
$13.79M
John Paulson
12 May 2020
Director
Buy indirect
678,400
$17.47
$11.85M
John Paulson
12 May 2020
Director
Buy indirect
374,836
$17.33
$6.50M
John Paulson
12 May 2020
Director
Buy indirect
162,900
$17.50
$2.85M
John Paulson
12 May 2020
Director
Buy indirect
25,000
$17.30
$432.50K
Thomas W. Ross Sr.
12 Mar 2020
Director
Buy
2,500
$15.54
$38.84K
Schutter Richard U De
10 Mar 2020
Director
Buy indirect
3,800
$18.26
$69.38K
Eschenbach Andrew C. Von
10 Mar 2020
Director
Buy
1,100
$18.18
$20.00K
Christina Ackermann
10 Mar 2020
EVP and General Counsel
Buy
4,390
$18.25
$80.11K
Schutter Richard U De
3 Mar 2020
Director
Buy
5,000
$23.08
$115.42K
Joseph C Papa
13 Sep 2019
Chairman & CEO
Buy
30,000
$23.31
$699.30K
William D. Humphries
16 Aug 2019
President, Ortho-Dermatologics
Buy
30,703
$21.18
$650.14K
Joseph C Papa
28 Feb 2019
Chairman & CEO
Buy
30,000
$23.67
$710.10K
Thomas Appio
14 Dec 2018
Pres&Co-Head Bausch&Lomb/Int'l
Buy
25,440
$22.96
$584.02K
Joseph C Papa
14 Sep 2018
Chairman & CEO
Buy
30,000
$22.32
$669.60K
Paul Herendeen
14 Sep 2018
EVP and CFO
Buy
10,000
$22.61
$226.10K
Schutter Richard U De
13 Sep 2018
Director
Buy
125,000
$23.96
$3.00M
Schutter Richard U De
15 May 2018
Director
Buy
15,000
$21.83
$327.45K
Schutter Richard U De
15 May 2018
Director
Buy indirect
10,000
$21.80
$218.00K
Joseph C Papa
13 Mar 2018
Chairman & CEO
Buy
30,000
$16.05
$481.50K
Paul Herendeen
13 Mar 2018
EVP and CFO
Buy
15,000
$16.10
$241.47K
Schutter Richard U De
8 Mar 2018
Director
Buy
10,000
$15.34
$153.40K
John Paulson
6 Mar 2018
Director
Buy indirect
7,066,629
$15.40
$108.83M
Schutter Richard U De
17 Nov 2017
Director
Buy
10,000
$14.33
$143.30K
John Paulson
16 Nov 2017
Director
Buy indirect
344,216
$14.40
$4.96M
Schutter Richard U De
21 Aug 2017
Director
Buy
4,900
$14.35
$70.32K
Schutter Richard U De
21 Aug 2017
Director
Buy
5,100
$14.31
$72.98K
Schutter Richard U De
11 May 2017
Director
Buy
20,000
$13.90
$278.00K
Schutter Richard U De
15 Mar 2017
Director
Buy
10,000
$10.80
$108.00K
ValueAct Holdings, L.P.
14 Mar 2017
Director
Buy indirect
2,500,000
$10.81
$27.03M
ValueAct Holdings, L.P.
14 Mar 2017
Director
Buy indirect
500,000
$10.88
$5.44M
Paul Herendeen
14 Mar 2017
EVP and CFO
Buy
24,000
$10.72
$257.28K
Thomas W. Ross Sr.
14 Dec 2016
Director
Buy
5,000
$14.73
$73.65K

What was left out

Form 4 filings counted 539
Amendments (4/A) skipped 22
Filings about a different issuer 2
Unreadable filings 0
Joint filings 12
Sales on a Rule 10b5-1 plan 15
Sales straight out of an exercise 5
Sales at will 23
Transactions with no price 0
Shares from compensation/vesting 18,345,887
Sales filed before the plan box existed 22
History held since 5 Jan 2010